Needham & Company Reiterates a 'Buy' on Gilead Sciences (GILD); 2Q11 Results Slightly Above Expectations; Upcoming 3Q11 Milestones in HIV are Key

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. GNK
3. PLUR
4. AZN
5. FNGR
6. NVDA
7. GSAT
8. S
9. AGPU
10. USO

Go back to Needham & Company Reiterates a 'Buy' on Gilead Sciences (GILD); 2Q11 Results Slightly Above Expectations; Upcoming 3Q11 Milestones in HIV are Key
Gilead Sciences (NASDAQ: GILD) Delayed: 137.57 -0.79 (0.57%)
Previous Close $138.36    52 Week High $108.63 
Open $138.36    52 Week Low $71.39 
Day High $138.38    P/E 76.01 
Day Low $136.63    EPS $1.81 
Volume 302,023